MSC - Page 25

Studying the Potential of Human Stem Cells for Treating Glaucoma

Glaucoma is a group of eye conditions that damage the optic nerve and lead to progressive, irreversible loss of vision. With over 80 million people affected by the condition, glaucoma is the second-leading cause of blindness, behind only age-related macular degeneration. Although there are several different risk factors, the most understood and treatable risk factor…

Treating Spinal Cord Injuries with Intravenous Infusion of Auto Serum-Expanded Autologous Mesenchymal Stem Cells

Spinal cord injury (SCI) continues to be a significant cause of disability. In fact, it is estimated that annual SCIs account for nearly 18,000 injuries in the United States and between 250,000 and 500,000 injuries worldwide[1]. Additionally, an estimated 294,000 people in the United States are currently living with some form of SCI, with males…

Treating Autoimmune Disease Through Adult Regenerative Medicine

Autoimmune diseases occur as a result of the body’s natural immune system mistakenly attacking and damaging healthy, normal cells and tissue. Currently, an estimated 60 different autoimmune diseases affect between 5 and 8 percent of the U.S. population[1]; making it one of the largest disease burdens faced today. Divided into two distinct categories, autoimmune diseases…

Mesenchymal Stem Cell-Based Therapy: Potential Benefits For Osteoarthritis

Affecting over 52 million people, or nearly 25% of the adult patients, osteoarthritis (OA) continues to be the leading cause of disability for people in the United States. Occurring as a result of the protective cartilage, or articular cartilage, that cushions the ends of the bones breaking down, OA can occur in any joint, but…

Exploring the Role of Stem Cells in Spinal Surgery

Recent breakthroughs in the field of regenerative medicine continue to support the tremendous healing potential of stem cell therapy.  Until a few years ago, stem cell research was limited to only what could be gathered from the research gathered from embryonic stem cells; this research was limited by the well-documented ethical concerns surrounding the practice…

Examining the Safety and Efficacy of Regenerative Medicine Treating Neural Damage in Patients with Multiple Sclerosis

Multiple sclerosis (MS) is a progressive and disabling autoimmune disease that affects the brain and central nervous system.  As MS progresses, the body’s immune system attacks the protective sheath (myelin) that covers nerve fibers resulting in axonal damage and loss that eventually results in paralysis of the limbs; the condition also contributes to a number…

The Benefits of Autologous Mesenchymal Stem Cell Transplant in Active Progressive Multiple Sclerosis

Progressive multiple sclerosis is a significant disruptive neurodegenerative disease that interferes with the brain’s ability to control the body; the condition continues to get worse over time and, to date, has no known therapeutic treatment or cure.  Petrou Et. Al’s double-blind clinical trial examined the therapeutic efficacy of mesenchymal stem cell (MSC) transplantation in active…

Considering the Therapeutic Treatment Potential of Mesenchymal Stem Cells in the Treatment of Glaucoma

Glaucoma is a complex group of interrelated eye conditions that affects over 70 million people worldwide.  A leading cause of irreversible blindness in people over 60, glaucoma is a progressive condition that affects the optic nerve and leads to gradual loss of specific neurons that relay visual information from the retina to the brain; the…

A Review of Safety and Clinical Effects of Neurotrophic Factor Transplantation in Patients with Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease or Lou Gehrig’s disease, is a disease that gradually paralyzes people because the brain is no longer able to communicate with the muscles of the body that we are typically able to move at will[1]; as ALS progresses, people will lose the ability to walk,…

Exploring the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells in Patients with Heart Failure

After a decade of research, the safety and efficacy of intravenous infusion of bone-marrow-derived stem cells for therapeutic treatment in individuals with heart failure have been well established; however, until Bartolucci et al’s phase 1 / 2 randomized controlled trial of intravenous infusion umbilical cord mesenchymal stem cells (UC-MSCs) on heart disease, no clinical studies…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.